Avantax Planning Partners’s DermTech, Inc. Common Stock DMTK Stock Holding History

Avantax Planning Partners’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-48,000	Closed	-$33.7K	–	495
2024 Q1	$33.7K	Buy	+48,000	New	+$54.2K	﹤0.01%	459

Other funds holding DMTK

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return

GWSA

Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return

T2I

Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Avantax Planning Partners's DMTK Position: Q2 2024 in Review

Avantax Planning Partners sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 48,000 shares — an estimated $33.7K sold.

Avantax Planning Partners first reported a position in DMTK in Q1 2024 and held it in 1 quarter. The position peaked at $33.7K in Q1 2024. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

Avantax Planning Partners reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Avantax Planning Partners sold 48,000 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $33.7K.
Avantax Planning Partners first reported a position in DermTech, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Avantax Planning Partners's DermTech, Inc. Common Stock position peaked at $33.7K in Q1 2024.
8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Avantax Planning Partners's 13F filing for Q2 2024, filed 9 Aug 2024.